亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

SP3.2.1 Management and outcomes of patients with small bowel obstruction in Denmark – a multicentre prospective cohort study

医学 放射性武器 保守管理 前瞻性队列研究 肠梗阻 队列 死亡率 队列研究 并发症 儿科 外科 内科学
作者
Henry Smith,Anders Peter Skovsen,Torben Pilegaard Jensen,Ida Lolle,Mette Astrup Tolver,Liv Bjerre Juul Nielsen
出处
期刊:British Journal of Surgery [Oxford University Press]
卷期号:109 (Supplement_5)
标识
DOI:10.1093/bjs/znac247.039
摘要

Abstract Aims The optimal management of small bowel obstruction (SBO) remains a matter of debate and treatment varies internationally. In Denmark, the traditional approach to patients with SBO is less conservative than that of the UK, but to what extent patient outcomes differ is unknown. This study aimed to describe the current management and outcomes of patients admitted with SBO in Denmark. Methods This was a prospective cohort study conducted at 6 acute hospitals in Denmark over a 4-month period. Patients aged > 18 years with a clinical or radiological diagnosis of SBO were eligible. Primary outcomes were 30-day mortality and major complication rates. Results 316 patients were included during the study period. The median age was 72 years and 56.0% were female. Diagnosis was made by computed tomography (CT) in 314 patients (99.1%), with the remaining 2 diagnosed clinically. Non-operative management was the initial strategy in 152 patients (48.1%) and successful in 120 (78.9%). Immediate surgery was performed in the remaining 164 (51.9%), with a laparoscopic approach used in 84 patients (51.2%). The 30-day mortality rate was 7.3% with major complications occurring in 61 patients (19.3%). Conclusions The management of SBO in Denmark differs significantly to that of the UK, with more liberal use of CT, a higher proportion of patients undergoing immediate surgery and a higher success rate of non-operative management. Despite these differences, patient outcomes are broadly similar. Adoption of the best components of both strategies may improve patient outcomes in both nations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学术扛把子完成签到 ,获得积分10
2秒前
情怀应助大大撒采纳,获得10
4秒前
4秒前
茉克发布了新的文献求助10
6秒前
李嘛耶发布了新的文献求助10
7秒前
20秒前
白华苍松发布了新的文献求助10
24秒前
积极鱼完成签到 ,获得积分10
28秒前
29秒前
科研通AI6.2应助贠子璇采纳,获得10
30秒前
30秒前
木有完成签到 ,获得积分10
36秒前
Orange应助科研通管家采纳,获得10
43秒前
43秒前
43秒前
打打应助科研通管家采纳,获得10
43秒前
科研通AI2S应助科研通管家采纳,获得10
44秒前
44秒前
大大撒发布了新的文献求助10
48秒前
53秒前
好运来完成签到 ,获得积分10
54秒前
包容仙人掌完成签到,获得积分10
55秒前
kingsunkang完成签到,获得积分10
56秒前
57秒前
1分钟前
kingsunkang发布了新的文献求助20
1分钟前
Jasper应助潇潇雨歇采纳,获得10
1分钟前
上岸应助嘻嘻哈哈采纳,获得80
1分钟前
1分钟前
CodeCraft应助冷艳清炎采纳,获得10
1分钟前
1分钟前
丘比特应助xiaoliaikeyan采纳,获得10
1分钟前
1分钟前
芜湖市吴奇隆完成签到,获得积分10
1分钟前
1分钟前
十七七发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6945563
求助须知:如何正确求助?哪些是违规求助? 8630839
关于积分的说明 18306462
捐赠科研通 6381817
什么是DOI,文献DOI怎么找? 3079742
关于科研通互助平台的介绍 2121403
邀请新用户注册赠送积分活动 2056653